Patrizio, L. & Cécile, O. (2026). Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management.. Acta cardiologica. https://doi.org/10.1080/00015385.2026.2705730
Patrizio L, Cécile O. Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management.. Acta cardiologica. 2026; doi: 10.1080/00015385.2026.2705730
Patrizio L, Cécile O. Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management.[J]. Acta cardiologica. 2026. DOI: 10.1080/00015385.2026.2705730.
@article{patrizio2026,
author = {Lancellotti Patrizio and Oury Cécile},
title = {Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management.},
journal = {Acta cardiologica},
year = {2026},
doi = {10.1080/00015385.2026.2705730},
note = {PMID: 42480041},
}
TY - JOUR AU - Lancellotti Patrizio AU - Oury Cécile TI - Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management. T2 - Acta cardiologica PY - 2026 DO - 10.1080/00015385.2026.2705730 AN - PMID:42480041 ER -
Cardiovascular medicine continues to move towards precision-based, individualised patient care, supported by novel biomarkers, refined imaging protocols, and multidisciplinary risk assessment. The studies featured in this issue of Acta Cardiologica span cardio-oncology, structural heart disease, immune and proteomic biomarkers, sepsis-related cardiac dysfunction, arrhythmia management, and vascular disease. Collectively, they underscore the growing importance of individualised diagnostic and therapeutic strategies across the cardiovascular spectrum, from cancer-related heart failure to conduction system pacing and cardiac arrest prevention.